Early-Clinical Research for Cell and Gene Therapy The development of Cell and Gene Therapies is challenging due to complex study designs, adequately monitoring of adverse reactions, long-term immune response and safety follow-up. BBCR has delivered clinical plans and regulatory strategies for Cell and Gene therapy programs in Oncology and Rare diseases.